Sarcoidosis Flashcards

1
Q

Sarcoidosis derives from Greek - sarco = __ ; eidos = __ ; osis = __

Definitiion: systemic inflammatory disorder of __ involving multiple organs, primarily __

A

Sarco = flesh ; eidos = like ; osis = condition

Non-caseating granuloma, lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Diagnostic criteria for sarcoidosis

A
  1. Consistent clinical and radiographic presentation
    - bilateral hilar adenopathy
  2. Histological evidence of non-caseating epitheloid granulomas in > 1 organ
  3. Excluded other granulomatous disease - mycobacterium, fungal, berylliosis, drugs, local reactions to tumours, lymphoma

Presumptive diagnosis can be made based on clinical and radiographic features alone
- Bilateral hilar adenopathy
- Lofgren syndrome
- Heerfordt syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of sarcoidosis

A
  1. Frequently affects African-Americans and northern Europeans
  2. Women > men
  3. Bimodal peak - 3rd to 4th decade; 6th decade (more in women)
  4. Higher prevalence in first generation relatives
  5. Obesity has higher risk of sarcoidosis
  6. Reduced risk in smokers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Immunopathologic features of sarcoidosis

A

Causes: genetics + environment
Reports of medication induced sarcoidosis: checkpoint inhibitors, HAART, IFNs, TNF-a antagonists

  1. Antigen-driven activation of macrophages and T-lymphocytes
    - MHC class II molecules on APC present antigen to CD4+ T helper lymphocytes resulting in amplified immune response and incerased secretion of cytokines
    - Incerased tissue permeability and cell migration
  2. Dysfunction of regulatory T cells and expansion of IL-17 and INF-g TH17 cells
  3. Clonal expansion of CD4+ T lymphocytes leading to persistent inflammation, non-caseating granuloma formation and fibrosis of affected organs

Manifestations in laboratory testing
1. BAL cell count: elevated lymphocytes, increased CD4/CD8 ratio (>3.5)
2. Peripheral blood lymphopenia (all sequestrated at inflammatory sites)
3. Low peripheral CD4/CD8 ratio
4. Polyclonal gammopathy
5. Autoantibody (low titre RF, ANA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Clinical presentation of sarcoidosis

A
  1. Asymptomatic with incidental abnormal CXR (bilateral hilar adenopathy)
  2. 95% intrathoracic involvement, and among them 50% extrathotacic involvement
    - However less than 1/2 actually has respiratory symptoms
    - Skin rashes, ophthalmologic involvement
    - Rarely cardiac or neurologic involvement
  3. 2% isolated extrathoracic involvement
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Respiratory tract manifestations of sarcoidosis

A

Entire respiratory tract from sinuses to lungs can be involved - thus a spectrum of manifestations
- Asymptomatic hilar adenoapthy
- Interstitial lung disease with alveolitis
- Pleural effusion
- Pulmonary hypertension (group V)

Symptoms and signs - non-specific
1. Dry cough
2. Dysapnoea
3. Chest pain
4. Haemoptysis

  1. Clubbing
  2. Crepitations
  3. +/- Wheeze (endobronchial involvement)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chest radiography staging of sarcoidosis
- Scadding staging system

A

Stages are not chronologic, does not indicate chronicity and does not correlate with lung function test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Extra-thoracic clinical manifestations of sarcoidosis

A

A. Non-specific symptoms - disabling fatigue (commonest 50%)

B. Cutaneous involvement
1. Skin rashes (33%) - erythema nodosum, subcutaneous nodules, papules, plaques
2. Tattoo/scar sarcoidosis
3. Lupus pernio

C. Ocular involvement - bilateral
4. Anterior uveitis
5. Lacrimal gland fibrosis - dry eyes, keratoconjunctivitis
6. Proptosis

D. Joint involvement
7. Inflammatory arthritis - acute or chronic
- Acute: Lofgren syndrome: oligo/polyarticular large joint swelling (commonest: ankles)
8. Osseous sarcoidosis (asymptomatic) - Phalanges
9. Skeletal muscle sarcoid myositis (<3%)

E. Systemic organ involvement
10. Hepatosplenomegaly and ALP transaminitis
11. Bilateral parotid enlargement, xerostomia
12. Neurological involvement in 5%
- Unilateral facial nerve palsy commonest, or any regions of brain and spinal cord
- Aseptic meningitis, encephalopathy, mass lesion
- Peripheral and small fibre neuropathy
13. Cardiac sarcoidosis in 5%
- Myocarditis, ventricular arrhythmias and conduction defectgs
14. Diabetes insipidus - HPA axis involvement
15. Sarcoidosis
16. Rarely affects kidney and GI tract

F. Haematologic involvement
16. Anaemia of chronic disease
17. Peripheral leukopenia (with organ/BAL leukocytosis and elevated CD4/CD8 ratio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Definitive and Supportive Investigations for sarcoidosis

A

Definitive investigations
1. Clinical features
2. CXR - bilateral hilar adenopathy
3. Biopsy of affected organ(s) with cell count and CD4/CD8 ratio

Supportive investigations
4. Elevated serum ACE x2 ULN (40-90%) - correlates with active pulmonary disease and normalise with therapy
(Produced by epitheloid and macrophages by ACE-inducing factor released by T cells)
- DDx: TB, coccidiodomycosis, Gaucher, hypersensitivity pneumonitis, silicosis, asbestosis, leprosy, hyperthyroidism, lung cancer, DM, genetic polymorphism
- Suppressed by ACEi
5. Elevated serum lysozme (70-80%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Correlating rheumatologic manifestations of sarcoidosis vs differentials

A
  1. Arthritis - Lofgren syndrome (25%)
    DDx: RA, gonococcal arthritis, rheumatic fever, SLE, gout, spondyloarthropathies
  2. Parotid gland enlargement (5%)
    DDx: Sjogren’s syndrome, IgG4-RD
  3. Upper airway disease (5-10%) - sinusitis, saddle nose deformity
    Ddx: granulomatosis polyangitis
  4. Anterior and posterior uveitis (20-30%)
    DDx: spondyloarthropathy, Behcet
  5. Proptosis (rare)
    DDx: GPA, IgG4-RD
  6. Myositis (3%)
    Ddx: polymyositis
  7. Mononeuritis multiplex, facial nerve palsy (1-2%)
    Ddx: systemic vasculitis, Lyme disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lofgren’s syndrome is a triad of __ (3)
Also associated with __ and __
Joint involvement usually __, duration ________
ACE level may be __, and if so are likely to have _____ arthritis
DDx: __ - to be excluded by serologies, urine antigen, cultures
Overall prognosis: ___

A

Triad of acute arthritis/periarthritis, erythema nodosum, bilateral hilar adenopathy
Associated with fever and uveitis

Joint involvement: arthritis/periarthritis of ankles
Duration self limiting, either resolves within weeks or persists up to 3 months

ACE level elevated - high likelihood of recurrent/persistent arthritis

Ddx: acute histoplasmosis

Overall prognosis: >90%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Heerfordt syndrome is also known as __
Tetrad of __ (5)
Mostly occur in __ (sex) and has a poor prognosis
Treatment with __ and __

A

Uveoparotid fever
Tetrad of: fever, parotid enlargement, uveitis, arthritis, facial nerve palsy
Occurs in males, poor prognosis
Treatment with mod dose corticosteroids, IST

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Comparison of acute and chronic sarcoid arthritis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How common does skeletal muscle sarcoidosis present?
How do they present clinically?

A

Sarcoid myopathy occurs in patients with multiorgan involvement
Mosty patients usually asymptomatic

Symptomatic:
1. Nodular myositis rarest - MRI dark star pattern in musculotendinous junctions
2. Acute granulomatous inflammatory myositis is rare, and indistinguishable from polymyositis
3. Chronic myositis (commonest) - insidious proximal symmetric muscle weakness and wasting, +/- neurogenic atrophy from granulomatous infiltration of nerves

Only acute myositis responds well to setroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Osseous sarcoidosis

A

3-13%, asymptomatic
Involves: phalanges of hands and feet, +/- axial bones
(spares MCPJ, MTPJ, wrists)

Features on radiography:
1. Trabecular pattern
2. Osteolysis
3. Cysts/punched out lesions

Imaging
1. Bone scans
2. MRI and PET-CT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of sarcoidosis

A

Most patients do not require treatment

Critical organ involvement:
1. Corticosteroids (1mg/kg per day), tapering down slowly over 6 months
2. When unable to taper < 10mg/day, choice of ISTs:
- Methotrexate 15-20mg weekly
- Azathioprine 2mg/kg daily
- Leflunomide 10-20mg/day
- MMF 1000-1500mg BD
3. If unresponding to IST + prednisolone, choice of anti-TNFa:
- Infliximab 5mg/kg every 4-6 weeks
- Adalimumab 40mg weekly

Specific organ involvement:
A. Cardiac involvement
- Cyclophosphamide
- Implantable pacemakers - arrhythmias, heart block

B. Cutaneous/musculoskeletal involvement
- Chloroquine/hydroxychloroquine

Last resort: solid organ transplant

17
Q

Monitoring of side effects of sarcoidosis treatment

A
  1. PJP prophylaxis while on high dose steroids
  2. Osteopenia and osteoporosis
  3. Vaccinations
  4. Depression - and referral to psychiatry
  5. Fatigue - can trial armodafinil, dexmethylphenidate
  6. Screen hypothyroidism, hypoxaemia
  7. Sleep apnoea
18
Q

Why do patients with sarcoidosis develop osteopenia/osteoporosis?

A
  1. Sarcoidosis direct bone lesion
    - Increased 1-a-hydroxylase enzyme in granulomas leading to increased calcitriol -> hypercalcaemia and hypercalciurea
    - May also cause nephrocalcinosis, renal dysfunction
  2. Corticosteroid induced osteoporosis
19
Q

Prognosis of sarcoidosis

A

> 60% spontaneous remission
(Additional 10-20% remit with corticosteroid)

< 25% develop new organ involvement within 2 years
10-30% chronic course

Worse prognosis in:
1. More than 3 organ system involvement
2. African-American
3. Age > 40 years
4. Symptoms > 6 months
5. Advanced radiographic stage of pulmonary disease
6. Pulmonary hypertension
7. Extrathoracic involvement (cardiac, neurologic, lupus pernio, panuveitis, hypercalcaemia, bone)

Mortality: 5%
- Half of them due to progressive pulmonary disease
- Another half due to cardiac or neurologic disease